Investors might want to bet on Inspire Medical Systems (INSP), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally ...

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with ...

Inspire Medical announced today that it received expanded FDA approval for its Inspire IV and V neuromodulation systems.

Inspire Medical Systems’ stock recently saw a significant surge, reacting to news that appears to be important. But does the increase from yesterday indicate that this is a good time to buy, or are we ...

Fourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Wednesday, 2026-02-11. Here's what investors need to know before the announcement. Analysts estimate that ...

What can you do now? You may be eligible to participate in the class action against Inspire Medical Systems, Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their ...

In its third-quarter 2025 investor letter, TimesSquare Capital U.S. Small Cap Growth Strategy highlighted stocks such as Inspire Medical Systems, Inc. (NYSE:INSP). Inspire Medical Systems, Inc.